United Kingdom · Question · Written question
UIN 38263
Dermatitis: Medical Treatments
Introduced
22 July 2021
Last action
6 September 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
6 September 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact on patients of the delay in technology appraisals for new eczema treatments as a result of ongoing capacity constraints at NICE.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 July 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact on patients of the delay in technology appraisals for new eczema treatments as a result of ongoing capacity constraints at NICE.
Source: Commons
6 September 2021
Answer
The Department has not made a specific assessment. The National Institute for Health and Care Excellence (NICE) is operationally independent from the Government. NICE is committed to publishing guidance close to the point of licensing wherever possible an...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-22/38263
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1349418
- uk · wq-1349418 · source updated 6 September 2021